Attenuated Vaccines MarketThe global attenuated vaccines market is set for significant expansion, with sales projected to ...

The influenza A virus genome consists of eight segments of single-stranded, negative-sense viral RNA, which encode multiple ...

Announcing a new article publication for Zoonoses journal. Vaccinia virus (VACV) confers cross-protective immunity against variola virus, the causative agent of smallpox, and has therefore been ...

Texas health officials now report 48 cases of measles, with 13 hospitalizations, mostly among children. All are unvaccinated ...

Biovet has secured a license from CDSCO for Biolumpivaxin, the world's only marker vaccine for Lumpy Skin Disease in cattle ...

Ervebo is a live-attenuated vaccine. That means it contains a weakened protein from EVD, which is not strong enough to cause a full infection but is just enough to trigger an immune response.

Hyderabad: Biovet, an arm of the Bharat Biotech group that makes animal health vaccines, received a licence from the Central ...

Biovet receives CDSCO license for LSD vaccine, a game-changer for animal health, developed in collaboration with ICAR.

The growth of the vaccine technologies market is driven by rise in prevalence of infectious diseases, growing trend towards preventive healthcare, and government immunization programs and initiatives.